Research Repository

Tavistock Adult Depression Study (TADS): A randomised controlled trial of psychoanalytic psychotherapy for treatment-resistant/treatment-refractory forms of depression

Taylor, D and Carlyle, JA and McPherson, S and Rost, F and Thomas, R and Fonagy, P (2012) 'Tavistock Adult Depression Study (TADS): A randomised controlled trial of psychoanalytic psychotherapy for treatment-resistant/treatment-refractory forms of depression.' BMC Psychiatry, 12. ISSN 1471-244X

[img]
Preview
Text
1471-244X-12-60.pdf - Published Version
Available under License Creative Commons Attribution.

Download (314kB) | Preview

Abstract

Background: Long-term forms of depression represent a significant mental health problem for which there is a lack of effective evidence-based treatment. This study aims to produce findings about the effectiveness of psychoanalytic psychotherapy in patients with treatment-resistant/treatment-refractory depression and to deepen the understanding of this complex form of depression.Methods/Design: INDEX GROUP: Patients with treatment resistant/treatment refractory depression. DEFINITION & INCLUSION CRITERIA: Current major depressive disorder, 2 years history of depression, a minimum of two failed treatment attempts, ≥14 on the HRSD or ≥21 on the BDI-II, plus complex personality and/or psycho-social difficulties. EXCLUSION CRITERIA: Moderate or severe learning disability, psychotic illness, bipolar disorder, substance dependency or receipt of test intervention in the previous two years. DESIGN: Pragmatic, randomised controlled trial with qualitative and clinical components. TEST INTERVENTION: 18 months of weekly psychoanalytic psychotherapy, manualised and fidelity-assessed using the Psychotherapy Process Q-Sort. CONTROL CONDITION: Treatment as usual, managed by the referring practitioner. RECRUITMENT: GP referrals from primary care. RCT MAIN OUTCOME: HRSD (with ≤14 as remission). SECONDARY OUTCOMES: depression severity (BDI-II), degree of co-morbid disorders Axis-I and Axis-II (SCID-I and SCID-II-PQ), quality of life and functioning (GAF, CORE, Q-les-Q), object relations (PROQ2a), Cost-effectiveness analysis (CSRI and GP medical records). FOLLOW-UP: 2 years. Plus: a). Qualitative study of participants' and therapists' problem formulation, experience of treatment and of participation in trial. (b) Narrative data from semi-structured pre/post psychodynamic interviews to produce prototypes of responders and non-responders. (c) Clinical case-studies of sub-types of TRD and of change.Discussion: TRD needs complex, long-term intervention and extended research follow-up for the proper evaluation of treatment outcome. This pushes at the limits of the design of randomised therapeutic trials. We discuss some of the consequent problems and suggest how they may be mitigated.Trial registration: Current Controlled Trials ISRCTN40586372. © 2012 Taylor et al; licensee BioMed Central Ltd.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Science and Health > Health and Social Care, School of
Depositing User: Jim Jamieson
Date Deposited: 13 Jan 2014 11:43
Last Modified: 27 Jun 2020 17:15
URI: http://repository.essex.ac.uk/id/eprint/8599

Actions (login required)

View Item View Item